Drupal.behaviors.print = function(context) {window.print();window.close();}>
Q&A: Illumina's Tina Hambuch on Clinical Whole-Genome Sequencing and CLIA Validation for NGS
April 25, 2012
Q&A: Illumina's Tina Hambuch on Clinical Whole-Genome Sequencing and CLIA Validation for NGS
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
After Pilot, Illumina Adds Clinical Interpretation as Option for Individual Genome Sequencing Service
November 28, 2012 / Clinical Sequencing News
Interpretation Remains Key Challenge in Clinical Sequencing; Patents May Impede Return of Results
June 27, 2012 / Clinical Sequencing News
Clinical Labs Must Navigate Tricky Regulatory Landscape for RUO Sequencing Products
April 11, 2012 / Clinical Sequencing News
FDA Mulls Options for Regulating Next-Gen Sequencing Platforms in Clinical Diagnostics
June 29, 2011 / Clinical Sequencing News
Researchers Report on Mutational Patterns in Adenoid Cystic Carcinoma
May 20, 2013 / GenomeWeb Daily News